Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Center for Drug Evaluation and Research
Biotech
CDER head Richard Pazdur retiring from FDA
Pazdur’s departure would send yet another shockwave through CDER, which is still reeling from the sudden exit of past leader George Tidmarsh.
Darren Incorvaia
Dec 2, 2025 12:55pm
Fierce Pharma
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
Nov 3, 2025 11:13am
FDA's principal deputy to depart agency—Chutes & Ladders
Dec 20, 2024 8:30am
Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders
Nov 22, 2024 8:30am
European orgs launch moonshot of their own for rare diseases
Dec 7, 2022 6:01pm
As FDA funding debated, CDER chief makes a pitch for new hires
Apr 5, 2022 10:00am
